A Review of Mycotoxins in Cannabis Flower - Kyle Boyar скачать в хорошем качестве

A Review of Mycotoxins in Cannabis Flower - Kyle Boyar

Tags: Cannabis Testing, Cannabis Regulations, Cannabis Mycotoxins, Compliance Testing, Microbial Contaminants Kyle Boyar, International Cannabis Field Application Scientist at ‪@BioRadLaboratoriesCorp‬, presents "A Review of Mycotoxins in Cannabis Flower" at CannMed 2025. In most states with legal cannabis frameworks, testing for five different mycotoxins - aflatoxins B1, B2, G1, & G2 and ochratoxin A is required. The levels of ochratoxin A and the combined levels of aflatoxin compounds must not exceed 20 ppb to achieve a passing result. This presentation examines detection and failure rates for these mycotoxins in cannabis flower across twelve US states (CA, CO, HI, IL, MD, MO, MS, NJ, NM, NV, OR, and WA). This work also highlights a growing body of literature that suggests mycotoxins derived from Fusarium spp. are prevalent microbial contaminants in cannabis flower and cannabis products. Learning Objectives: ⦾ The five mycotoxins that most states currently test for rarely exceed the 20 ppb action level in cannabis flowers. ⦾ There are other mycotoxins derived from Fusarium spp. that are more commonly found in cannabis flowers and cannabis products 0:00 - Intro 0:39 - Current Mycotoxin Regulations in the US 1:22 - The Cannabis Mycobiome: Fungi of Concern 2:36 - Fungal Infections and Mycotoxin Production 3:17 - Health Effects of Mycotoxins in Cannabis 5:12 - Fusarium-Derived Mycotoxins and Production Factors 7:32 - Mycotoxin Detection and Failure Rates in Flower 8:53 - Mycotoxin Detection in Cannabis Concentrates 9:48 - Are Mycotoxin Detections Real? 10:49 - California's Mycotoxin Failure Rates 11:22 - The Practice of Extracting Moldy Biomass 12:24 - Fusarium Mycotoxins and Their Health Effects 14:00 - Poster Presentation: Fusarium Mycotoxins in Oregon 15:23 - Mycotoxins in CBD Products and Isolate 16:25 - Research on Fusarium Infection and Mycotoxin Levels 17:58 - Mycotoxins in Black and Gray Market Cannabis 19:08 - The Inside-Out Nature of Fusarium Infection 20:06 - Preliminary Results on Mycotoxins in Legal Samples 21:01 - Mycotoxins and Cannabis Hyperemesis Syndrome 21:44 - Conclusion: The Need for New Mycotoxin Screening 22:45 - Acknowledgments and Future Directions Learn More about CannMed: https://cannmedevents.com/ Sign Up for Our Newsletter: https://share.hsforms.com/1oi57oJDnRN... The CannMed 25 Innovation & Investment Summit showcased its first international venue, the Wyndham Grand Rio Mar Golf & Beach Resort in Puerto Rico from June 17 - 20, 2025. Since its inception at Harvard Medical School in 2016, CannMed has earned a reputation as the premier destination for cutting-edge research, emerging technologies, and investment opportunities. CannMed 25 continues this tradition with medicinal plant researchers, clinicians and venture capitalists who view this Summit as the industry’s number one showcase for the latest advances in plant-based science, medicine, cultivation, and safety.